卵巢癌组织学类型：作为重要预后和预测标志物的出现 - Suppr | 超能文献

Ovarian Carcinoma Histotypes: Their Emergence as Important Prognostic and Predictive Markers.

作者信息

Gilks C Blake, Kommoss Friedrich

出版信息

Oncology (Williston Park). 2016 Feb;30(2):178-9.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Ovarian Carcinoma Histotypes: Their Emergence as Important Prognostic and Predictive Markers.卵巢癌组织学类型：作为重要预后和预测标志物的出现

Oncology (Williston Park). 2016 Feb;30(2):178-9.

2

Molecular Pathology of Ovarian Epithelial Neoplasms: Predictive, Prognostic, and Emerging Biomarkers.卵巢上皮性肿瘤的分子病理学：预测性、预后性和新兴生物标志物。

Surg Pathol Clin. 2021 Sep;14(3):415-428. doi: 10.1016/j.path.2021.05.006.

3

Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.上皮性卵巢癌生物标志物检测的建议：西班牙病理学会和西班牙肿瘤内科学会的国家共识声明。

Clin Transl Oncol. 2018 Mar;20(3):274-285. doi: 10.1007/s12094-017-1719-x. Epub 2017 Aug 16.

4

HE4: another 'player' in the epithelial tumor marker arena?

Oncology (Williston Park). 2013 Jun;27(6):556, 562-3.

5

Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumors using biomarkers or the ROMA algorithm.

Gynecol Oncol. 2013 Aug;130(2):398-9. doi: 10.1016/j.ygyno.2013.04.472. Epub 2013 May 6.

6

Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumours using biomarkers or the ROMA algorithm.

Gynecol Oncol. 2013 Aug;130(2):400. doi: 10.1016/j.ygyno.2013.04.471. Epub 2013 May 6.

7

HE4--another marker for gynecologic cancers: do we really need one?

Oncology (Williston Park). 2013 Jun;27(6):563, 566.

8

Prognostic impact of epithelial cell adhesion molecule in ovarian cancer patients.上皮细胞粘附分子对卵巢癌患者的预后影响

J Gynecol Oncol. 2014 Oct;25(4):352-4. doi: 10.3802/jgo.2014.25.4.352.

9

LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer.LINE-1甲基化水平作为上皮性卵巢癌的潜在预后因素。

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):711-7. doi: 10.1111/j.1525-1438.2007.01117.x. Epub 2007 Oct 18.

10

A review and an update on the screening of epithelial ovarian cancer.上皮性卵巢癌筛查的综述与更新

Curr Probl Cancer. 2006 Sep-Oct;30(5):203-32. doi: 10.1016/j.currproblcancer.2006.06.001.

引用本文的文献

1

Ovarian cancer: diagnostic accuracy and tumor types distribution in East Africa compared to North America.卵巢癌：与北美相比，东非的诊断准确性和肿瘤类型分布。

Diagn Pathol. 2020 Jul 16;15(1):86. doi: 10.1186/s13000-020-01000-3.

2

Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.卵巢癌组织学类型：将形态学与免疫组织化学预测相结合的优势和局限性。

Int J Gynecol Pathol. 2019 Jul;38(4):353-362. doi: 10.1097/PGP.0000000000000530.

3

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.COEUR 加拿大卵巢癌生物标志物验证队列的特征和结局。

BMC Cancer. 2018 Mar 27;18(1):347. doi: 10.1186/s12885-018-4242-8.